CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101

Clinical trial NCT06152172 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06152172
Sponsor: David Porter
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Inflammatory Myopathies Diffuse Cutaneous Systemic Sclerosis SLE Nephritis ANCA Associated Vasculitis

Start date: 2024-08-05
Primary completion: 2027-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.